Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris

Stratmann B, Farr M, Tschesche H (2001)
BIOLOGICAL CHEMISTRY 382(6): 987-991.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
Stratmann, B; Farr, M; Tschesche, HaraldUniBi
Einrichtung
Fakultät für Chemie > Biochemie I
Abstract / Bemerkung
The tight regulation of extracellular matrix remodeling and degradation is of great importance in physiological processes like development and morphogenesis, as well as in pathological situations like tumor invasion and metastasis. Tissue inhibitors of metalloproteinases (TIMPs) are the naturally occuring inhibitors of matrix metalloproteinases, which are involved in matrix turnover. In this report we describe the cloning of human TIMP-4 from a human adenocarcinoma and an osteosarcoma cell line and the expression of the inhibitory domain in the methylotrophic yeast Pichia pastoris. The inhibition of MMP-8, -9, -12, -13 and -14 by the N-terminal domain of TIMP-4 was analysed. Using a fluorescent MCA-peptide, K-i values for each subclass of MMPs were determined. With dissociation constants in the nanomolar range, TIMP-4 seems to be a good inhibitor for all classes of MMPs without remarkable preference for special MMPs.
Stichworte
matrix metalloproteinase (MMP); tissue inhibitor of; metalloproteinases (TIMP); Pichia pastoris
Erscheinungsjahr
2001
Zeitschriftentitel
BIOLOGICAL CHEMISTRY
Band
382
Ausgabe
6
Seite(n)
987-991
ISSN
1431-6730
Page URI
https://pub.uni-bielefeld.de/record/1616669

Zitieren

Stratmann B, Farr M, Tschesche H. Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. BIOLOGICAL CHEMISTRY. 2001;382(6):987-991.
Stratmann, B., Farr, M., & Tschesche, H. (2001). Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. BIOLOGICAL CHEMISTRY, 382(6), 987-991. https://doi.org/10.1515/BC.2001.124
Stratmann, B, Farr, M, and Tschesche, Harald. 2001. “Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris”. BIOLOGICAL CHEMISTRY 382 (6): 987-991.
Stratmann, B., Farr, M., and Tschesche, H. (2001). Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. BIOLOGICAL CHEMISTRY 382, 987-991.
Stratmann, B., Farr, M., & Tschesche, H., 2001. Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. BIOLOGICAL CHEMISTRY, 382(6), p 987-991.
B. Stratmann, M. Farr, and H. Tschesche, “Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris”, BIOLOGICAL CHEMISTRY, vol. 382, 2001, pp. 987-991.
Stratmann, B., Farr, M., Tschesche, H.: Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. BIOLOGICAL CHEMISTRY. 382, 987-991 (2001).
Stratmann, B, Farr, M, and Tschesche, Harald. “Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris”. BIOLOGICAL CHEMISTRY 382.6 (2001): 987-991.

11 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Roles and regulation of the matrix metalloproteinase system in parturition.
Geng J, Huang C, Jiang S., Mol Reprod Dev 83(4), 2016
PMID: 26888468
Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
Ji MK, Shi Y, Xu JW, Lin X, Lin JY., Anticancer Drugs 24(5), 2013
PMID: 23442578
Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
Heard BJ, Martin L, Rattner JB, Frank CB, Hart DA, Krawetz R., BMC Musculoskelet Disord 13(), 2012
PMID: 22824140
Tissue inhibitor of matrix metalloproteinases 4 (TIMP4) in a population of young adults: relations to cardiovascular risk markers and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study.
Oikonen M, Wendelin-Saarenhovi M, Siitonen N, Sainio A, Juonala M, Kähönen M, Lyytikäinen LP, Seppälä I, Lehtimäki T, Viikari JS, Järveläinen H, Raitakari OT., Scand J Clin Lab Invest 72(7), 2012
PMID: 22978719
Bioengineering embryonic stem cell microenvironments for the study of breast cancer.
Raof NA, Mooney BM, Xie Y., Int J Mol Sci 12(11), 2011
PMID: 22174624
Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes.
Huang W, Mabrouk ME, Sylvester J, Dehnade F, Zafarullah M., Open Rheumatol J 5(), 2011
PMID: 22216069
Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload.
Koskivirta I, Kassiri Z, Rahkonen O, Kiviranta R, Oudit GY, McKee TD, Kytö V, Saraste A, Jokinen E, Liu PP, Vuorio E, Khokha R., J Biol Chem 285(32), 2010
PMID: 20516072
Modulation of angiogenesis by tissue inhibitor of metalloproteinase-4.
Fernández CA, Moses MA., Biochem Biophys Res Commun 345(1), 2006
PMID: 16682001
The TIMPs tango with MMPs and more in the central nervous system.
Crocker SJ, Pagenstecher A, Campbell IL., J Neurosci Res 75(1), 2004
PMID: 14689443
Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.
Peterson JT., Heart Fail Rev 9(1), 2004
PMID: 14739769
MMP-TIMP interaction depends on residue 2 in TIMP-4.
Stratmann B, Farr M, Tschesche H., FEBS Lett 507(3), 2001
PMID: 11696356

26 References

Daten bereitgestellt von Europe PubMed Central.

Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
Bigg HF, Shi YE, Liu YE, Steffensen B, Overall CM., J. Biol. Chem. 272(24), 1997
PMID: 9182583
Tissue inhibitors of metalloproteinases: evolution, structure and function.
Brew K, Dinakarpandian D, Nagase H., Biochim. Biophys. Acta 1477(1-2), 2000
PMID: 10708863
The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations.
Butler GS, Hutton M, Wattam BA, Williamson RA, Knauper V, Willenbrock F, Murphy G., J. Biol. Chem. 274(29), 1999
PMID: 10400663

AUTHOR UNKNOWN, 0
The N-terminus of collagenase MMP-8 determines superactivity and inhibition: a relation of structure and function analyzed by biomolecular interaction analysis.
Farr M, Pieper M, Calvete J, Tschesche H., Biochemistry 38(22), 1999
PMID: 10353844
Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K., EMBO J. 17(17), 1998
PMID: 9724659
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W., Nature 389(6646), 1997
PMID: 9288970
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP., Eur. J. Cell Biol. 74(2), 1997
PMID: 9352216
Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4.
Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE., J. Biol. Chem. 271(48), 1996
PMID: 8939999
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII.
Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H., J. Biol. Chem. 275(42), 2000
PMID: 10930399
Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
Huang W, Meng Q, Suzuki K, Nagase H, Brew K., J. Biol. Chem. 272(35), 1997
PMID: 9268350
Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M., Cancer Res. 56(11), 1996
PMID: 8653693
Preparation of active recombinant TIMP-1 from Escherichia coli inclusion bodies and complex formation with the recombinant catalytic domain of PMNL-collagenase.
Kleine T, Bartsch S, Blaser J, Schnierer S, Triebel S, Valentin M, Gote T, Tschesche H., Biochemistry 32(51), 1993
PMID: 8260495
A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG, Willenbrock F, Murphy G., FEBS Lett. 296(3), 1992
PMID: 1537400
Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE., Structure 3(6), 1995
PMID: 8590015
The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
Lichte A, Kolkenbrock H, Tschesche H., FEBS Lett. 397(2-3), 1996
PMID: 8955363
Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4).
Liu YE, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE., J. Biol. Chem. 272(33), 1997
PMID: 9252358
Residue 2 of TIMP-1 is a major determinant of affinity and specificity for matrix metalloproteinases but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate.
Meng Q, Malinovskii V, Huang W, Hu Y, Chung L, Nagase H, Bode W, Maskos K, Brew K., J. Biol. Chem. 274(15), 1999
PMID: 10187802
Relating matrix metalloproteinase structure to function: why the "hemopexin" domain?
Murphy G, Knauper V., Matrix Biol. 15(8-9), 1997
PMID: 9138283
The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity.
Murphy G, Houbrechts A, Cockett MI, Williamson RA, O'Shea M, Docherty AJ., Biochemistry 30(33), 1991
PMID: 1868085
High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3.
Muskett FW, Frenkiel TA, Feeney J, Freedman RB, Carr MD, Williamson RA., J. Biol. Chem. 273(34), 1998
PMID: 9705310
Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris.
Roderfeld M, Buttner FH, Bartnik E, Tschesche H., Protein Expr. Purif. 19(3), 2000
PMID: 10910727
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 270(10), 1995
PMID: 7890645
Latent collagenase and gelatinase from human neutrophils and their activation.
Tschesche H, Knauper V, Kramer S, Michaelis J, Oberhoff R, Reinke H., Matrix Suppl 1(), 1992
PMID: 1480034
Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.
Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM, Shi YE., Oncogene 14(23), 1997
PMID: 9190892
Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
Woessner JF Jr., FASEB J. 5(8), 1991
PMID: 1850705
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 11501766
PubMed | Europe PMC

Suchen in

Google Scholar